Immunogenic oncolysis by tigilanol tiglate
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
Immunogenic oncolysis by tigilanol tiglate.
JG Pol, M Lizarralde-Guerrero, G Kroemer - Oncoimmunology, 2024 - europepmc.org
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
Immunogenic oncolysis by tigilanol tiglate
JG Pol, M Lizarralde-Guerrero… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
[HTML][HTML] Immunogenic oncolysis by tigilanol tiglate
JG Pol, M Lizarralde-Guerrero, G Kroemer - Oncoimmunology, 2024 - ncbi.nlm.nih.gov
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
Immunogenic oncolysis by tigilanol tiglate.
JG Pol, M Lizarralde-Guerrero, G Kroemer - Oncoimmunology, 2024 - europepmc.org
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …
study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell …